Your browser doesn't support javascript.
loading
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.
Visanji, Naomi P; Bhudhikanok, Grace S; Mestre, Tiago A; Ghate, Taneera; Udupa, Kaviraj; AlDakheel, Amaal; Connolly, Barbara S; Gasca-Salas, Carmen; Kern, Drew S; Jain, Jennifer; Slow, Elizabeth J; Faust-Socher, Achinoam; Kim, Sam; Azhu Valappil, Ruksana; Kausar, Farah; Rogaeva, Ekaterina; William Langston, J; Tanner, Caroline M; Schüle, Birgitt; Lang, Anthony E; Goldman, Samuel M; Marras, Connie.
Afiliação
  • Visanji NP; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Bhudhikanok GS; The Parkinson's Institute and Clinical Center, Sunnyvale, California, USA.
  • Mestre TA; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Ghate T; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Udupa K; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.
  • AlDakheel A; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Connolly BS; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Gasca-Salas C; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Kern DS; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Jain J; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Slow EJ; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Faust-Socher A; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Kim S; The Parkinson's Institute and Clinical Center, Sunnyvale, California, USA.
  • Azhu Valappil R; The Parkinson's Institute and Clinical Center, Sunnyvale, California, USA.
  • Kausar F; The Parkinson's Institute and Clinical Center, Sunnyvale, California, USA.
  • Rogaeva E; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
  • William Langston J; The Parkinson's Institute and Clinical Center, Sunnyvale, California, USA.
  • Tanner CM; University of California, San Francisco, San Francisco, California, USA.
  • Schüle B; San Francisco Veterans Affairs Health Care System, San Francisco, California, USA.
  • Lang AE; The Parkinson's Institute and Clinical Center, Sunnyvale, California, USA.
  • Goldman SM; Morton and Gloria Shulman Movement Disorders Centre and Edmund J Saffra Program in Parkinson's Disease, Tornto Western Hospital, Toronto, Ontario, Canada.
  • Marras C; University of California, San Francisco, San Francisco, California, USA.
Mov Disord ; 32(4): 610-614, 2017 04.
Article em En | MEDLINE | ID: mdl-28071824
ABSTRACT

BACKGROUND:

Heart rate variability is reduced in idiopathic PD, indicating cardiac autonomic dysfunction likely resulting from peripheral autonomic synucleinopathy. Little is known about heart rate variability in leucine-rich repeat kinase 2-associated PD.

OBJECTIVES:

This study investigated heart rate variability in LRRK2-associated PD.

METHODS:

Resting electrocardiograms were obtained from 20 individuals with LRRK2-associated PD, 37 nonmanifesting carriers, 48 related noncarriers, 26 idiopathic PD patients, and 32 controls. Linear regression modelling compared time and frequency domain values, adjusting for age, sex, heart rate, and disease duration.

RESULTS:

Low-frequency power and the ratio of low-high frequency power were reduced in idiopathic PD versus controls (P < .008, P < .029 respectively). In contrast, individuals with LRRK2-associated PD were not statistically different from controls in any parameter measured. Furthermore, all parameters trended toward being higher in LRRK2-associated PD when compared with idiopathic PD.

CONCLUSIONS:

Heart rate variability may remain intact in LRRK2-associated PD, adding to a growing literature supporting clinical-pathologic differences between LRRK2-associated and idiopathic PD. © 2017 International Parkinson and Movement Disorder Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina / Cardiopatias / Frequência Cardíaca / Mutação Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina / Cardiopatias / Frequência Cardíaca / Mutação Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá